H1N1 News and Research

RSS

Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company’s RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.

22 Oct 2009

More infants are being immunized but funding gap leaves millions of children still at risk

Reversing a downward trend, immunization rates are now at their highest ever and vaccine development worldwide is booming, according to a new assessment released today by the World Health Organization (WHO), UNICEF and the World Bank.

22 Oct 2009

eHealthInsurance releases answers for FAQs on swine flu and their health insurance

eHealthInsurance (NASDAQ: EHTH) today released a list of answers to questions frequently asked from people concerned about the H1N1 virus (also called swine flu) and their health insurance, who have called into its Customer Care Center, which includes a call center staffed with licensed insurance agents. Getting answers to these questions is particularly important for high-risk individuals: pregnant women, children and seniors.

22 Oct 2009

“Sid the Science Kid” show to explain the science behind flu vaccinations

Health and Human Services Secretary Kathleen Sebelius, Education Secretary Arne Duncan, and Lisa Henson, CEO of the Jim Henson Company, will join Washington-area school children for a screening of the new “Sid the Science Kid” special episode on the flu at the U.S. Department of Education Auditorium.

22 Oct 2009

Awareness campaign to educate families on H1N1 flu virus, seasonal flu and common cold

Dial Complete Antibacterial Foaming Hand Wash, the #1 doctor-recommended brand, today announced it is working together with other leading brands to raise awareness and educate families to ‘Plan, Prepare and Defend’ against the H1N1 flu virus, seasonal flu and the common cold.

22 Oct 2009

FDA uses Wolters Kluwer Pharma Solutions' prescription data for tracking viral treatments

Wolters Kluwer Pharma Solutions, Inc., a leading provider of market data and competitive intelligence to the pharmaceutical and biotech industries, announced today that the Food and Drug Administration (FDA) is using its prescription data to track the treatment of H1N1 and other influenza viruses.

22 Oct 2009

Emerging Pandemic Threats program to combat newly emerging diseases of animal origin

The United States Agency for International Development (USAID) is launching an Emerging Pandemic Threats (EPT) program that builds on the successes of the Agency's long-standing programs in disease surveillance, training, and outbreak response, particularly those addressing avian and pandemic influenza.

22 Oct 2009

Women more likely than men to curb swine flu

A new American Red Cross poll shows that while concerns about exposure to the H1N1 (swine flu) virus remain high, women are more likely than men to make extra efforts to cover coughs and sneezes with tissue, wash their hands more carefully and use hand sanitizer more often.

22 Oct 2009

Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities

The Swine Flu (H1N1)Vaccine is starting to arrive at health departments, hospitals, and community vaccinator facilities.

21 Oct 2009

Novavax, Xcellerex enter into collaboration to accelerate the development of Novavax's 2009 H1N1 vaccine

Novavax, Inc. and Xcellerex, Inc. have entered into a strategic collaboration to accelerate the development of Novavax's vaccine manufacturing process to commercial scale and begin immediate production of Novavax's novel 2009 H1N1 influenza vaccine for potential commercial sale.

21 Oct 2009

Study suggests superiority of CT scans over X-Rays in detecting abnormalities in patients with the H1N1 virus

Computed tomography (CT) scans are better than standard radiography (X-rays) in showing the extent of disease in patients with the H1N1 virus, according to a study to be published online Oct. 21, 2009, in the American Journal of Roentgenology. The study will be published in the December issue of the AJR.

21 Oct 2009

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

Aethlon Medical, Inc. announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus. The Hemopurifier® is the first-in-class medical device able to selectively remove infectious viruses and immunosuppressive proteins from the bloodstream.

21 Oct 2009

MUSC launches Social Media Newsroom for real-time information on medical news and research

As the editorial landscape continues to evolve with the emergence of social media, many people struggle to find trusted resources that offer accurate, real time information related to healthcare news and research.

21 Oct 2009

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

Weekly Digest (http://www.bullmarket.com/digest), a free investment research publication, announced the publication of a special report on investment opportunities in connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for GlaxoSmithKline, Sanofi-Aventis, Novartis, Baxter International, Roche Holding and several others.

21 Oct 2009

New public health tool to identify all Tier 1 candidates for H1N1 vaccination

Practice Fusion Inc. (www.practicefusion.com), the free, web-based electronic health record (EHR) for physicians, today implemented a first-of-its-kind tool that allows its physician-users to immediately and accurately identify all Tier 1 candidates for H1N1 vaccination from their patient populations using criteria published by the Centers for Disease Control and Prevention (CDC).

21 Oct 2009

Swine flu treatments, safety issues prompt health workers to speak out

In anticipation of new swine flu cases, medical workers are looking for new ways help their patients - and protect themselves.

21 Oct 2009

CHA urges California Nurses Association to promote vaccinations to all health care workers

The California Hospital Association (CHA) is engaged with hospitals and state and local public health officials in a voluntary statewide effort to ensure that all hospital workers -- including registered nurses -- are vaccinated against the H1N1 flu virus.

21 Oct 2009

Grady Memorial Hospital uses LiveProcess event log for emergency healthcare management

Facilities like Atlanta, Georgia-based Grady Memorial Hospital are taking extra precautions, including leveraging technology for emergency healthcare management, in anticipation of a H1N1 surge this fall.

21 Oct 2009

Nationwide H1N1 Event Log to help ongoing challenges of flu pandemic

LiveProcess launched a nationwide H1N1 Event Log on October 1 designed to help regional healthcare organizations more effectively deal with the expected patient surge, consolidate the massive flow of disease-related communications and coordinate regional events with their constituent hospitals and other healthcare facilities.

21 Oct 2009

Rice University scientists win NIH stimulus funds to study influenza A

Rice University scientists have won a $1.5 million grant from the National Institutes of Health to scrutinize the influenza A virus for clues that could lead to more effective antiviral drugs. Strains of influenza A include this year's pandemic H1N1 variety, some seasonal varieties and the much-feared H5N1 bird flu.

21 Oct 2009

H1N1 News and Research

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

More infants are being immunized but funding gap leaves millions of children still at risk

eHealthInsurance releases answers for FAQs on swine flu and their health insurance

“Sid the Science Kid” show to explain the science behind flu vaccinations

Awareness campaign to educate families on H1N1 flu virus, seasonal flu and common cold

FDA uses Wolters Kluwer Pharma Solutions' prescription data for tracking viral treatments

Emerging Pandemic Threats program to combat newly emerging diseases of animal origin

Women more likely than men to curb swine flu

Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities

Novavax, Xcellerex enter into collaboration to accelerate the development of Novavax's 2009 H1N1 vaccine

Study suggests superiority of CT scans over X-Rays in detecting abnormalities in patients with the H1N1 virus

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

MUSC launches Social Media Newsroom for real-time information on medical news and research

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

New public health tool to identify all Tier 1 candidates for H1N1 vaccination

Swine flu treatments, safety issues prompt health workers to speak out

CHA urges California Nurses Association to promote vaccinations to all health care workers

Grady Memorial Hospital uses LiveProcess event log for emergency healthcare management

Nationwide H1N1 Event Log to help ongoing challenges of flu pandemic

Rice University scientists win NIH stimulus funds to study influenza A

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News